NDC 0121-4820 – Theophylline
Theophylline 80 mg/15mL · Solution · Oral
Product NDC0121-4820
Product details
- Brand name
- Theophylline
- Generic name
- Theophylline
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA206344
- Marketed since
- December 16, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Methylxanthine
Active ingredients
- Theophylline 80 mg/15mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-4820-40 | 4 TRAY in 1 CASE (0121-4820-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-4820-15) | Dec 16, 2016 |
Other Theophylline products
- 17856-0038 Theophylline Anhydrous 80 mg/15mL · Solution · ATLANTIC BIOLOGICALS CORP.
- 72162-2038 Theophylline Anhydrous 80 mg/15mL · Solution · Bryant Ranch Prepack
- 71335-2909 Theophylline Anhydrous 80 mg/15mL · Solution · Bryant Ranch Prepack
- 68999-556 Theophylline Anhydrous 80 mg/15mL · Solution · Chartwell Governmental & Specialty RX, LLC.
- 62135-556 Theophylline Anhydrous 80 mg/15mL · Solution · Chartwell RX, LLC
- 27808-033 Theophylline Anhydrous 80 mg/15mL · Solution · Cranbury Pharmaceuticals, LLC
- 0121-0820 Theophylline 80 mg/15mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 27241-272 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 27241-273 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 62332-026 Theophylline Anhydrous 450 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-025 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-025 Theophylline Anhydrous 300 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited